Bessissow T - Search Results

1

Management of colorectal neoplasia in IBD patients: current practice and future perspectives.

Derks MEW, Te Groen M, van Lierop LMA, Murthy S, Rubin DT, Bessissow T, Nagtegaal ID, Bemelman WA, Derikx LAAP, Hoentjen F. Derks MEW, et al. Among authors: bessissow t. J Crohns Colitis. 2024 May 14:jjae071. doi: 10.1093/ecco-jcc/jjae071. Online ahead of print. J Crohns Colitis. 2024. PMID: 38741227

2

Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study.

Shehab M, Alrashed F, Alyaseen M, Safar Z, Adekunle T, Alfadhli A, Bessissow T. Shehab M, et al. Among authors: bessissow t. Vaccines (Basel). 2024 Mar 27;12(4):364. doi: 10.3390/vaccines12040364. Vaccines (Basel). 2024. PMID: 38675746 Free PMC article.

3

Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system.

Bacsur P, Wetwittayakhlang P, Resál T, Földi E, Vasas B, Farkas B, Rutka M, Bessissow T, Afif W, Bálint A, Fábián A, Bor R, Szepes Z, Farkas K, Lakatos PL, Molnár T. Bacsur P, et al. Among authors: bessissow t. Therap Adv Gastroenterol. 2024 Mar 21;17:17562848241239606. doi: 10.1177/17562848241239606. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38524790 Free PMC article.

4

Novel and emerging drugs for the treatment of Crohn's disease: a review of phase II and III trials.

Wetwittayakhlang P, Bessissow T, Lakatos PL. Wetwittayakhlang P, et al. Among authors: bessissow t. Expert Opin Emerg Drugs. 2024 Mar;29(1):19-34. doi: 10.1080/14728214.2024.2303116. Epub 2024 Jan 11. Expert Opin Emerg Drugs. 2024. PMID: 38193191 Review.

5

Comparative Efficacy of Advanced Therapies for Achieving Endoscopic Outcomes in Crohn's Disease: A Systematic Review and Network Meta-Analysis.

Vuyyuru SK, Nguyen TM, Murad MH, Narula N, Bessissow T, Zou G, McCurdy JD, Peyrin-Biroulet L, Danese S, Ma C, Singh S, Jairath V. Vuyyuru SK, et al. Among authors: bessissow t. Clin Gastroenterol Hepatol. 2024 Jan 6:S1542-3565(24)00003-X. doi: 10.1016/j.cgh.2023.12.023. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38185396 Review.

6

A Case Report and Literature Review of a Rare Jejunal Solitary Peutz-Jeghers-Type Polyp Resected Endoscopically in an Elderly Patient Presenting with Subacute Gastrointestinal Bleeding.

Alenezi T, Marcus V, Bessissow T. Alenezi T, et al. Among authors: bessissow t. Case Rep Gastrointest Med. 2023 Dec 18;2023:2391602. doi: 10.1155/2023/2391602. eCollection 2023. Case Rep Gastrointest Med. 2023. PMID: 38146326 Free PMC article.

7

Characteristics of Interventional Trials for Patients Living With Intestinal Stoma Registered in ClinicalTrials.gov With a Focus on Inflammatory Bowel Disease.

Vuyyuru SK, Ma C, Sharma T, Nguyen TM, Bessissow T, Narula N, Singh S, Rieder F, Jairath V. Vuyyuru SK, et al. Among authors: bessissow t. Inflamm Bowel Dis. 2023 Dec 22:izad293. doi: 10.1093/ibd/izad293. Online ahead of print. Inflamm Bowel Dis. 2023. PMID: 38135729

8

Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.

McCurdy JD, Munir J, Parlow S, Reid J, Yanofsky R, Alenezi T, Meserve J, Becker B, Lahijanian Z, Eddin AH, Mallick R, Ramsay T, Rosenfeld G, Bessissow A, Bessissow T, Jairath V, Singh S, Bruining DH, Macdonald B; Canadian IBD Research Consortium. McCurdy JD, et al. Among authors: bessissow t. Clin Gastroenterol Hepatol. 2024 May;22(5):1058-1066.e2. doi: 10.1016/j.cgh.2023.12.006. Epub 2023 Dec 18. Clin Gastroenterol Hepatol. 2024. PMID: 38122958

9

Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study.

Bessissow T, Narula N, Ma C, In TSH, Eberg M, Karra K, Jairath V; Canadian IBD Research Consortium. Bessissow T, et al. Dig Liver Dis. 2024 Jan;56(1):61-69. doi: 10.1016/j.dld.2023.08.042. Epub 2023 Sep 15. Dig Liver Dis. 2024. PMID: 37716860

10

Histological Disease Activity as Predictor of Clinical Relapse, Hospitalization, and Surgery in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.

Shehab M, Al Akram S, Hassan A, Alrashed F, Jairath V, Bessissow T. Shehab M, et al. Among authors: bessissow t. Inflamm Bowel Dis. 2024 Apr 3;30(4):563-572. doi: 10.1093/ibd/izad119. Inflamm Bowel Dis. 2024. PMID: 37541185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

132 results

Search Page